Security Snapshot

TENET HEALTHCARE CORP - Common Stock (THC) Institutional Ownership

CUSIP: 88033G407

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

697

Shares (Excl. Options)

84,545,002

Price

$198.72

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
THC on NYSE
Shares outstanding
87,110,513
Price per share
$188.71
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
84,545,002
Total reported value
$16,803,101,745
% of total 13F portfolios
0.01%
Share change
+1,068,655
Value change
+$204,281,787
Number of holders
697
Price from insider filings
$188.71
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • THC - TENET HEALTHCARE CORP - Common Stock is tracked under CUSIP 88033G407.
  • 697 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 697 to 335 between Q4 2025 and Q1 2026.
  • Reported value moved from $16,803,101,745 to $3,424,623,377.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 697 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 88033G407?
CUSIP 88033G407 identifies THC - TENET HEALTHCARE CORP - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of TENET HEALTHCARE CORP - Common Stock (THC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.8% $1,024,603,493 8,391,511 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $864,671,673 4,582,013 Vanguard Capital Management 31 Mar 2026
Invesco Ltd. 4.4% $509,469,088 4,172,556 Invesco Ltd. 31 Mar 2025

As of 31 Dec 2025, 697 institutional investors reported holding 84,545,002 shares of TENET HEALTHCARE CORP - Common Stock (THC). This represents 97% of the company’s total 87,110,513 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TENET HEALTHCARE CORP - Common Stock (THC) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 8,856,018 -1.7% 0.03% $1,759,867,896
BlackRock, Inc. 9.8% 8,535,892 -0.12% 0.03% $1,696,252,460
FMR LLC 8.8% 7,642,182 -3.4% 0.08% $1,518,654,423
PRICE T ROWE ASSOCIATES INC /MD/ 8.6% 7,490,350 +1.6% 0.16% $1,488,484,000
Boston Partners 4.2% 3,642,136 +16% 0.75% $723,804,310
STATE STREET CORP 3.1% 2,693,391 -1.4% 0.02% $535,230,660
AQR CAPITAL MANAGEMENT LLC 2.6% 2,256,539 +20% 0.24% $448,419,394
GLENVIEW CAPITAL MANAGEMENT, LLC 2.3% 1,983,753 -15% 8.4% $394,211,396
Invesco Ltd. 2.3% 1,975,267 -7.1% 0.06% $392,525,036
LONE PINE CAPITAL LLC 2.1% 1,787,326 2.6% $355,177,423
AMERIPRISE FINANCIAL INC 2% 1,738,959 -5.3% 0.08% $345,568,365
GEODE CAPITAL MANAGEMENT, LLC 2% 1,723,563 -3.1% 0.02% $342,575,314
DIMENSIONAL FUND ADVISORS LP 1.5% 1,275,779 -4.2% 0.05% $253,540,559
NORGES BANK 1.4% 1,250,473 0.03% $248,493,995
BANK OF AMERICA CORP /DE/ 1.4% 1,198,072 +11% 0.02% $238,080,869
D. E. Shaw & Co., Inc. 1.4% 1,189,512 +60% 0.18% $236,379,825
Nuveen, LLC 1.3% 1,155,677 +12% 0.06% $229,656,134
WELLINGTON MANAGEMENT GROUP LLP 1.3% 1,135,801 +1114% 0.04% $225,706,374
Allianz Asset Management GmbH 1% 868,134 +78% 0.2% $172,515,587
MORGAN STANLEY 0.97% 840,693 +5.8% 0.01% $167,063,023
NORTHERN TRUST CORP 0.88% 770,443 -3.8% 0.02% $153,102,433
ALLIANCEBERNSTEIN L.P. 0.85% 740,490 -1.6% 0.05% $147,150,173
VICTORY CAPITAL MANAGEMENT INC 0.84% 731,575 +19% 0.08% $145,378,584
RAYMOND JAMES FINANCIAL INC 0.75% 649,239 -1.7% 0.04% $129,191,873
Bank of New York Mellon Corp 0.74% 646,397 -10% 0.02% $128,451,941

Institutional Holders of TENET HEALTHCARE CORP - Common Stock (THC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 18,152,257 $3,424,623,377 -$159,081,329 $188.71 335
2025 Q4 84,545,002 $16,803,101,745 +$204,281,787 $198.72 697
2025 Q3 83,524,934 $16,956,383,383 -$548,485,967 $203.04 673
2025 Q2 86,705,205 $15,256,042,920 -$242,114,800 $176.00 619
2025 Q1 88,102,608 $11,848,580,868 -$297,990,635 $134.50 557
2024 Q4 90,782,644 $11,460,937,238 +$74,973,470 $126.23 571
2024 Q3 88,853,987 $14,755,648,870 -$388,930,023 $166.20 596
2024 Q2 92,054,252 $12,246,548,506 -$231,494,763 $133.03 522
2024 Q1 93,979,649 $9,878,072,066 +$21,023,735 $105.11 448
2023 Q4 95,052,239 $7,183,420,124 -$61,999,835 $75.57 420
2023 Q3 96,023,570 $6,326,878,906 -$70,153,915 $65.89 405
2023 Q2 95,766,096 $7,793,537,068 -$238,287,442 $81.38 410
2023 Q1 99,389,967 $5,903,975,587 -$260,800,223 $59.42 359
2022 Q4 104,685,581 $5,107,056,484 -$189,448,183 $48.79 349
2022 Q3 107,996,779 $5,568,387,416 +$91,465,890 $51.58 346
2022 Q2 105,740,110 $5,559,583,262 -$63,755,091 $52.56 347
2022 Q1 105,282,868 $9,052,535,353 +$282,827,156 $85.96 388
2021 Q4 102,521,862 $8,374,229,051 +$119,235,986 $81.69 361
2021 Q3 100,968,332 $6,709,151,477 +$55,798,127 $66.44 326
2021 Q2 100,293,045 $6,718,584,522 +$246,651,010 $66.99 314
2021 Q1 97,408,920 $5,065,644,752 -$60,322,413 $52.00 299
2020 Q4 99,122,344 $3,958,107,321 -$64,323,227 $39.93 264
2020 Q3 102,234,584 $2,504,131,936 +$7,053,786 $24.51 234
2020 Q2 102,228,001 $1,850,912,849 +$1,244,953 $18.11 224
2020 Q1 104,884,711 $1,510,464,449 -$62,618,800 $14.40 240
2019 Q4 103,527,921 $3,934,674,864 -$213,112,670 $38.03 256
2019 Q3 109,824,690 $2,428,280,890 +$92,511,192 $22.12 235
2019 Q2 105,979,797 $2,185,403,553 +$35,545,953 $20.66 235
2019 Q1 103,605,019 $2,986,181,928 +$15,127,630 $28.84 251
2018 Q4 104,460,437 $1,789,770,177 -$126,837,659 $17.14 254
2018 Q3 108,937,826 $3,099,894,673 +$63,271,498 $28.46 250
2018 Q2 106,334,815 $3,569,754,759 -$165,762,173 $33.57 242
2018 Q1 112,004,501 $2,716,128,701 -$112,384,909 $24.25 227
2017 Q4 120,099,329 $1,820,709,170 -$113,671,487 $15.16 223
2017 Q3 127,841,674 $2,100,033,634 +$145,149,848 $16.43 233
2017 Q2 117,323,436 $2,268,906,016 +$91,431,122 $19.34 234
2017 Q1 113,160,326 $2,003,985,108 +$458,866,205 $17.71 241
2016 Q4 101,576,997 $1,507,446,454 +$4,383,004 $14.84 247
2016 Q3 99,036,234 $2,242,080,002 -$49,420,243 $22.66 253
2016 Q2 100,077,533 $2,766,065,984 -$40,378,140 $27.64 249
2016 Q1 101,442,845 $2,934,194,257 -$50,722,671 $28.93 261
2015 Q4 102,781,234 $3,113,900,998 -$26,532,051 $30.30 268
2015 Q3 101,393,770 $3,743,094,540 +$37,675,701 $36.92 303
2015 Q2 98,165,333 $5,680,747,480 +$36,900,177 $57.88 327
2015 Q1 98,167,318 $4,857,964,129 +$154,125,547 $49.51 303
2014 Q4 95,006,721 $4,811,470,511 -$57,730,542 $50.67 313
2014 Q3 95,528,364 $5,673,545,364 -$56,755,342 $59.39 306
2014 Q2 97,262,068 $4,565,394,023 +$16,257,278 $46.94 284
2014 Q1 98,620,050 $4,221,007,463 +$260,249,863 $42.81 282
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .